Results for Specimens

1 - 10 of 51

Dr. Muir investigates the mechanisms underlying esophageal fibrosis to improve therapeutic and diagnostic approaches.

E-mail:

muira [at] chop.edu

Dr. Cole is a pediatric neuro-oncologist who has dedicated her career to translational and clinical research, combining her expertise in molecular pathology, cancer genomics, and developmental therapeutics to identify novel treatments for children with cancer.

E-mail:

colek [at] chop.edu

Suzanne P. MacFarland, MD

Dr. MacFarland's research focuses on syndromes that predispose to cancer development in children and adolescents. She has initiated several individual and collaborative research projects, working in pediatric polyposis syndromes and Li-Fraumeni syndrome. She is uncovering novel genomic drivers of disease and identifying biomarkers of cancer onset and progression.

E-mail:

macfarlands [at] chop.edu

Diva D. De León-Crutchlow, MD, MSCE

Dr. De Leon-Crutchlow’s translational research program focuses on examining the pathophysiology of disorders of insulin regulation, identifying novel therapeutic targets, and developing new therapies for these conditions. The program approach includes patient-oriented research and bench research employing mouse models and primary islet cultures.

E-mail:

deleon [at] chop.edu

A new CHOP Neuroscience Center is opening!

Published on

Dec 10, 2021

in Announcements

A new CHOP Neuroscience Center is opening!

This announcement provides a brief introduction to the newly formed CHOP Neuroscience Center.

Guest Blog: Hack-a-thon Reveals Unexpected Collaboration With Airline Industry Volunteers

Published on

Oct 27, 2021

in Cornerstone Blog

CHOP and Airline Industry Employees Collaborate in Hack-a-thon

A rare disease hack-a-thon leads to an unusual collaboration between D3b’s bioinformaticians, including Adam Resnick, PhD, and American Airlines’ software engineers.